Zobrazeno 1 - 10
of 115
pro vyhledávání: '"E Krenning"'
Autor:
M. Pavel, E. Baudin, A. Couvelard, E. Krenning, K. Öberg, T. Steinmüller, M. Anlauf, B. Wiedenmann, R. Salazar, B. C. Conference Anlauf M, Arnold R, Bartsch D, Baudin E, Baum R, Brandi ML, Cadiot G, Costa F, Caplin M, Couvelard A, de Herder W, Delle Fave G, Denecke T, Eriksson B, Gress T, Gross D, Grossman A, Jensen R, Kaltsas G, Kelestimur F, Kianmanesh R, Klöppel G, Klose KJ, Knigge U, Komminoth P, Kos Kudla B, Krenning E, Kwekkeboom D, Lopes JM, Niederle B, Nilsson O, Öberg K, O'Connor J, O'Toole D, Pape UF, Papotti M, Pascher A, Pavel M, Perren A, Plöckinger U, Rindi G, Ruszniewski P, Salazar R, Sasano H, Sauvanet A, Scoazec JY, Steinmüller T, Sundin A, Taal B, Tomassetti P, Van Cutsem E, Vullierme MP, Wiedenmann B., FALCONI , MASSIMO
Publikováno v:
Neuroendocrinology, 95(2), 157-176. Karger
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
Autor:
James C. Yao, F. Giammarile, Eric Baudin, J. Strosber, R. Guimbaud, Jean Francois Seitz, T. Matysiac, Andrew Eugene Hendifar, Frédéric Courbon, David Taïeb, E. Krenning, R. Lebtahi, Michel Ducreux, Catherine Ansquer, Philippe Ruszniewski, Catherine Lombard-Bohas
Publikováno v:
Annales d'Endocrinologie. 77:257-258
NETTER-1 est une etude de phase III, multicentrique internationale, stratifiee, ouverte, randomisee, evaluant une radiotherapie interne vectorisee (RIV) par 177 Lu-Dotatate chez les patients porteurs de TNE de l’intestin moyen de grade 1–2 inoper
Autor:
J. Ramage, P. Goretzki, R. Manfredi, P. Komminoth, D. Ferone, R. Hyrdel, G. Kaltsas, F. Kelestimur, L. Kvols, J. Scoazec, M. S. Garcia, M. Caplin, H. Ahlman, R. Arnold, C. Auernhammer, E. Christ, A. Couvelard, W. D. Herder, G. D. Fave, B. Eriksson, D. Gross, R. Jensen, R. Kianmanesh, G. Klöppel, W. Knapp, U. Knigge, M. Körner, B. Kos Kudła, E. Krenning, M. Kulke, D. Kwekkeboom, J. Lopes, A. McNicol, B. Niederle, G. Nikou, O. Nilsson, K. Öberg, J. O'Connor, D. O'Toole, U. Pape, M. Pavel, A. Perren, U. Plöckinger, J. Ricke, G. Rindi, P. Ruszniewski, R. Salazar, A. Scarpa, T. Steinmüller, A. Sundin, B. Taal, M. Vullierme, B. Wiedenmann, S. Wildi, J. Yao, FALCONI , MASSIMO
Publikováno v:
Neuroendocrinology, 87(1), 31-39. Karger
a Department of Gastroenterology, North Hampshire Hospital, Basingstoke , UK; b Stadtisches Klinikum Neuss, Lukaskrankenhaus, Chirurgische Klinik I, Neuss , Germany; c Istituto di Radiologia, Policlinco GB Rossi, Verona , Italy; d Institute for Patho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4266a333610c8f194ca60098294b229e
https://avesis.erciyes.edu.tr/publication/details/8768ad6b-3126-4115-be30-c055e614adb6/oai
https://avesis.erciyes.edu.tr/publication/details/8768ad6b-3126-4115-be30-c055e614adb6/oai
Publikováno v:
Clinical Otolaryngology. 19:290-294
Seventy-five patients with Graves' disease have been treated by transantral orbital decompression. In the first post-operative month the average reduction in proptosis was 3 mm. In the years following the operation this reduction increased to an aver
Autor:
JC Reubi, B Waser, U Horisberger, E Krenning, SW Lamberts, JO Gebbers, P Gersbach, JA Laissue
Publikováno v:
Blood. 82:2143-2151
Receptors for the neuropeptide somatostatin (SS) were evaluated in vitro and in vivo in various human lymphatic tissues, ie, thymus, spleen, and lymph nodes; thymic carcinoids and thymomas were also tested. The receptors were measured in vitro using
Publikováno v:
Metabolism. 39:78-81
Specific receptors for somatostatin (SS), mediating the various actions of this peptide, have been described in SS target tissues in animal and man. Using homogenate binding assays, as well as receptor autoradiography, the presence of SS receptors ha
Autor:
D. Williams, E. Krenning, M. Schlumberger, J. Lazarus, C. Beckers, A. Burger, W. D. Alexander
Publikováno v:
European Journal of Nuclear Medicine. 23:BP13-BP15
Autor:
M C, Smith, J, Liu, T, Chen, H, Schran, C M, Yeh, F, Jamar, R, Valkema, W, Bakker, L, Kvols, E, Krenning, S, Pauwels
Publikováno v:
Digestion. 62
OctreoTher ((90)Y-DOTA-D-Phe(1)-Tyr(3)-octreotide, a.k.a. (90)Y-SMT 487) consists of a somatostatin peptide analogue (Tyr(3)-octreotide), coupled with a complexing moiety (DOTA), and labeled with a tightly bound beta-emitter (yttrium-90). By targetin
Autor:
A, Elhendy, Zoet-NugterenS, J H, Cornel, P M, Fioretti, A J, Bogers, J R, Roelandt, E, Krenning, J, Postma-Tjoa, J, McGhie, S E, Spitaels
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 37(5)
Exercise 201TI SPECT has been used as a useful method for the assessment of patients with anomalous left coronary artery communicating to the pulmonary artery (ALCAPA syndrome). In this study, we described an adult patient with this anomaly who was e
Autor:
J C, Reubi, B, Waser, U, Horisberger, E, Krenning, S W, Lamberts, J O, Gebbers, P, Gersbach, J A, Laissue
Publikováno v:
Blood. 82(7)
Receptors for the neuropeptide somatostatin (SS) were evaluated in vitro and in vivo in various human lymphatic tissues, ie, thymus, spleen, and lymph nodes; thymic carcinoids and thymomas were also tested. The receptors were measured in vitro using